During the last session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s traded shares were 3.63 million, with the beta value of the company hitting 1.16. At the end
During the last session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s traded shares were 3.13 million, with the beta value of the company hitting 1.16. At the end
In the last trading session, 5.4 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) were traded, and its beta was 1.16. Most recently the company’s
In the last trading session, 2.57 million Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares changed hands as the company’s beta touched 1.16. With the company’s per share
In the last trading session, 2.93 million Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares changed hands as the company’s beta touched 1.17. With the company’s per share
In last trading session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) saw 2.59 million shares changing hands with its beta currently measuring 1.25. Company’s recent per share price
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has a beta value of 1.24 and has seen 20.96 million shares traded in the last trading session. The company, currently
During the recent session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s traded shares were 11.03 million, with the beta value of the company hitting 1.24. At the last
In the last trading session, 4.11 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) were traded, and its beta was 1.28. Most recently the company’s
In today’s recent session, 0.58 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) have been traded, and its beta is 1.28. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
